MK-2206 window of opportunity study in breast cancer

le Akcakanat, Argun, Meric-Bernstam, Funda
Foilsithe in Ann Transl Med (2018)

Targeting translation initiation in breast cancer

le Akcakanat, Argun, Hong, David S, Meric-Bernstam, Funda
Foilsithe in Translation (Austin) (2014)

The rapamycin-regulated gene expression signature determines prognosis for breast cancer

le Akcakanat, Argun, Zhang, Li, Tsavachidis, Spiridon, Meric-Bernstam, Funda
Foilsithe 2009

RAPAMYCIN REGULATES THE PHOSPHORYLATION OF RICTOR

le Akcakanat, Argun, Singh, Gopal, Hung, Mien-Chie, Meric-Bernstam, Funda
Foilsithe 2007

Targeting the PI3-kinase/Akt/mTOR Signaling Pathway

le Hassan, Burhan, Akcakanat, Argun, Holder, Ashley M., Meric-Bernstam, Funda
Foilsithe 2013

Comparison of Akt/mTOR Signaling in Primary Breast Tumors and Matched Distant Metastases

le Akcakanat, Argun, Sahin, Aysegul, Shaye, Alexandra N., Velasco, Marco A., Meric-Bernstam, Funda
Foilsithe 2008

RNA-binding specificity of Y-box protein 1

le Dong, Jinjiang, Akcakanat, Argun, Stivers, David N., Zhang, Jiexin, Kim, Doyil, Meric-Bernstam, Funda
Foilsithe in RNA Biol (2009)

Effect of Leucine Restriction on Akt/mTOR Signaling in Breast Cancer Cell Lines In Vitro and In Vivo

le Singh, Gopal, Akcakanat, Argun, Sharma, Chandeshwar, Luyimbazi, David, Naff, Katherine A., Meric-Bernstam, Funda
Foilsithe in Nutr Cancer (2011)

eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling

le Soni, Alpana, Akcakanat, Argun, Singh, Gopal, Luyimbazi, David, Zheng, Yuhuan, Kim, Doyil, Gonzalez-Angulo, Ana, Meric-Bernstam, Funda
Foilsithe 2008

Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss

le Owusu-Brackett, Nicci, Zhao, Ming, Akcakanat, Argun, Evans, Kurt W., Yuca, Erkan, Dumbrava, Ecaterina Ileana, Janku, Filip, Meric-Bernstam, Funda
Foilsithe in Oncotarget (2020)

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer

le Owusu-Brackett, Nicci, Evans, Kurt W., Akcakanat, Argun, Yuca, Erkan, Tapia, Coya, Rizvi, Yasmeen Qamar, Dumbrava, Ecaterina Ileana, Janku, Filip, Meric-Bernstam, Funda
Foilsithe in Oncotarget (2019)

Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer

le Meric-Bernstam, Funda, Chen, Huiqin, Akcakanat, Argun, Do, Kim-Anh, Lluch, Ana, Hennessy, Bryan T, Hortobagyi, Gabriel N, Mills, Gordon B, Gonzalez-Angulo, Ana Maria
Foilsithe 2012

Epithelial to mesenchymal transition is associated with rapamycin resistance

le Holder, Ashley M., Akcakanat, Argun, Adkins, Farrell, Evans, Kurt, Chen, Huiqin, Wei, Caimiao, Milton, Denai R., Li, Yisheng, Do, Kim-Anh, Janku, Filip, Meric-Bernstam, Funda
Foilsithe in Oncotarget (2015)

High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients

le Holder, Ashley M., Gonzalez-Angulo, Ana M., Chen, Huiqin, Akcakanat, Argun, Do, Kim-Anh, Symmans, W. Fraser, Pusztai, Lajos, Hortobagyi, Gabriel N., Mills, Gordon B., Meric-Bernstam, Funda
Foilsithe 2012

Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer

le Sangai, Takafumi, Akcakanat, Argun, Chen, Huiqin, Tarco, Emily, Wu, Yun, Do, Kim-Anh, Miller, Todd W., Arteaga, Carlos L., Mills, Gordon B., Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda
Foilsithe 2012

Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

le Arango, Natalia Paez, Yuca, Erkan, Zhao, Ming, Evans, Kurt W., Scott, Stephen, Kim, Charissa, Gonzalez-Angulo, Ana Maria, Janku, Filip, Ueno, Naoto T., Tripathy, Debu, Akcakanat, Argun, Naing, Aung, Meric-Bernstam, Funda
Foilsithe in Breast Cancer Res (2017)

Rapamycin regulates Stearoyl CoA Desaturase 1 Expression in Breast Cancer

le Luyimbazi, David, Akcakanat, Argun, McAuliffe, Priscilla F., Zhang, Li, Singh, Gopal, Gonzalez-Angulo, Ana Maria, Chen, Huiqin, Do, Kim-Anh, Zheng, Yuhuan, Hung, Mien-Chie, Mills, Gordon B., Meric-Bernstam, Funda
Foilsithe 2010

Weekly nab-Rapamycin in Patients with Advanced Nonhematologic Malignancies: Final Results of a Phase 1 Trial

le Gonzalez-Angulo, Ana M., Meric-Bernstam, Funda, Chawla, Sant, Falchook, Gerald, Hong, David, Akcakanat, Argun, Chen, Huiqin, Naing, Aung, Fu, Siqing, Wheler, Jennifer, Moulder, Stacy, Helgason, Thorunn, Li, Shaoyi, Elias, Ileana, Desai, Neil, Kurzrock, Razelle
Foilsithe 2013

Genomic, Transcriptomic and Proteomic Profiling of Metastatic Breast Cancer

le Akcakanat, Argun, Zheng, Xiaofeng, Pico, Christian X. Cruz, Kim, Tae-Beom, Chen, Ken, Korkut, Anil, Sahin, Aysegul, Holla, Vijaykumar, Tarco, Emily, Singh, Gopal, Damodaran, Senthil, Mills, Gordon B., Gonzalez-Angulo, Ana Maria, Meric-Bernstam, Funda
Foilsithe in Clin Cancer Res (2021)

PIK3CA/PTEN Mutations and Akt Activation as Markers of Sensitivity to Allosteric mTOR inhibitors

le Meric-Bernstam, Funda, Akcakanat, Argun, Chen, Huiqin, Do, Kim-Anh, Sangai, Takafumi, Adkins, Farrell, Gonzalez-Angulo, Ana Maria, Rashid, Asif, Crosby, Katherine, Dong, Mei, Phan, Alexandria T., Wolff, Robert A., Gupta, Sanjay, Mills, Gordon B., Yao, James
Foilsithe 2012